Advertisement

Topics

Companies Related to "Sugary Soda Tied Higher Risk Chronic Kidney Disease" [Most Relevant Company Matches] RSS

22:14 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Sugary Soda Tied Higher Risk Chronic Kidney Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Sugary Soda Tied Higher Risk Chronic Kidney Disease" Companies 1–25 of 4,300+

Extremely Relevant

The Kidney TRUST

Founded in 2006, the TRUST is a non-profit organization dedicated to reducing the human and economic cost of kidney disease. The TRUST is focused on increasing awareness of chronic kidney disease (CKD) through public education and testing programs so that progression of CKD to kidney failure can be delayed or prevented. The TRUST is also developing innovative solutions to address the critical un...


Thrasos Therapeutics

Thrasos TherapeuticsTM is a private, clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The Company is advancing therapeutic programs, led by THR-184, for renal diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD). Thrasos’...

Relevant

Tianjin Soda Plant

In 1917,Tianjin Soda Plant was established at the coast of Bohai Sea in Tanggu District,Tianjin City with the original name of "Yong Li Soda Plant" The founders are Mr. Fan Xudong, Chinese famous patriotic entrepreneur , and Dr. Hou Debang, world famous scientist and authority of soda industry. It is the first soda plant in Asia with Solvey Process and well known as the cradle of Chinese Soda Indu...


Kibow Biotech Inc

Kibow Biotech Inc. was founded in 1997 by Dr. N. Ranganathan and Dr. Jack Dickstein. Kibow Biotech Inc. started out to fill the void in treatments for patients with chronic kidney disease. Since then Kibow Biotech Inc. has been actively researching on ways and methods to develop a cost-effective non-invasive treatment for kidney disease patients. This has since became our mission statement. The co...

CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...

NephroGenex, Inc.

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have end stage renal disease requiring dialysis, making renal disease one of the costliest illnesses to treat. The Company is developing Pyridorin(TM) (pyridoxamine dihydrochloride) as a treatment to slow t...

Kidney Research UK

Kidney disease is not, as commonly thought, a disease that affects only the elderly - it can happen at any age. Treatment options include a transplant - for which there is a waiting list or a life on dialysis, a life sustaining treatment - but which can severely restrict daily life.Founded in 1961, Kidney Research UK is the leading UK charity funding research that focuses on the prevention, treatm...

Glycominds Ltd.

Glycominds, a commercial stage molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Our proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.

Fibrotech Therapeutics

Fibrotech is an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis (tissue scarring). The Company develops novel anti-fibrotic drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as chronic kidney disease, chronic heart failure, pulmonary fibros...

Satellite Healthcare, Inc. Satellite Healthcare

Satellite Healthcare, Inc., founded in 1974, is one of the nation's first not-for-profit providers of dialysis services and kidney disease care. With its expanded offerings Satellite Healthcare provides early patient wellness education, personalized clinical services and a complete range of dialysis therapy choices. This comprehensive offering allows Satel...

Patient Engagement Systems® (PES)

Patient Engagement Systems® (PES) is a nationally recognized healthcare services company dedicated to supporting its customers’ goal of helping people with chronic diseases, specifically diabetes and chronic kidney disease, improve their health, and reduce costs related to inpatient admissions and ER visits. PES provides medical groups, IPAs, health ...

Thrasos, Inc.

Thrasos is a private, clinical stage, bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The Company has advanced two compounds, THR-184 and THR-123, into development for Acute Kidney Injury (AKI) and Chronic Kidney Injury (CKD), respectively, and initiated Phase 1 cli...

Patient Engagement Systems

Patient Engagement Systems® (PES) is a nationally recognized healthcare services company dedicated to supporting its customers’ goal of helping people with chronic diseases, specifically diabetes and chronic kidney disease, improve their health, and reduce costs related to inpatient admissions and ER visits. PES provides medical groups, IPAs, health ...

DaVita Labs

DaVita Labs, a division operating within DaVita Inc., provides quality, on-time, accurate results to help effectively identify and manage kidney patients across the nation. As a cutting-edge chronic kidney disease (CKD) specialty laboratory, DaVita Labs features the latest in end stage renal disease-specific methodology and technology for delivering quality ...

Ortho Biotech

In 1990, Ortho Biotech was established as the first biotechnology subsidiary of Johnson & Johnson.Today, our products and treatments combat some of the most serious diseases - such as cancer, HIV/AIDS, and chronic kidney disease. They also help restore the health and comfort of patients undergoing elective surgery, organ transplants, and chemotherapy.We are a leader in the worldwide treatment of a...

Satellite Healthcare, Inc.

Satellite Healthcare, Inc. is one of the nation's first and leading providers of dialysis services and kidney disease care. With its affiliated services - Satellite WellBound, Satellite Dialysis and Satellite Research, Satellite Healthcare provides early patient wellness education, personalized clinical services and a complete range of dialysis therapy choices. This comprehensive offering allows S...

Nanobiotech

NanoBiotech is a life science company that discovers, develops, and manufactures novel nanobiotics designed to improve people's health through the treatment of diseases associated with pathological calcification, inflammation and nanobacterial infections. Our Founders’ pioneering research has established the role of Nanobacteria in pathological calcification: particularly in the development o...

The Partnership to Fight Chronic Disease New Jersey

The Partnership to Fight Chronic Disease (PFCD) is an internationally-recognized NGO of patients, providers, community organizations, business and labor groups, and health policy experts committed to raising awareness of the number one cause of death, disability, and rising health care costs: chronic disease. For a collection of statistics and commentary o...

National Kidney Foundation Singapore

The World Kidney Fund was established as an international fund by the National Kidney Foundation Singapore to help kidney patients in developing countries who have little or no access to renal healthcare facilities. Through this fund, training programmes are developed to empower non-profit kidney organisations to establish sustainable life-saving kidney healthcare programmes. The World Kidney Fun...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and gr...

Partnership to Fight Chronic Disease (PFCD) and UnitedHealthcare

The Partnership to Fight Chronic Disease (PFCD) is a national coalition of patients, providers, community organizations, business and labor groups, and health policy experts committed to raising awareness of the number one cause of death, disability, and rising health care costs in the U.S.: chronic disease.

HealthReveal

HealthReveal is a healthcare technology company whose mission is to preempt the avoidable consequences of chronic disease. A fundamental component of fulfilling this mission is ensuring patients receive guideline-directed medical therapy. Patients suffering from chronic disease receive guideline-directed medical therapy only about 50% of the time1. The con...

EPOGEN® (Epoetin alfa)

EPOGEN® (Epoetin alfa), one of the first biologic human therapeutics, is approved for the treatment of anemia in patients with chronic kidney disease who are on dialysis.

Aranesp® (darbepoetin alfa)

Aranesp® (darbepoetin alfa) is approved for the treatment of anemia associated with chronic kidney disease and chemotherapy.

National Kidney Foundation

The National Kidney Foundation, with offices throughout the country, is dedicated to preventing and treating kidney and urinary tract diseases, improving the health and well being of individuals and families affected by these diseases and increasing availability of all organs for transplantation. More at www.kidney.org.


More From BioPortfolio on "Sugary Soda Tied Higher Risk Chronic Kidney Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks